Skip to main content

Advertisement

Table 4 Parameters from ROC analysis on serum Trx1 levels between patients with breast and other cancers

From: Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses

Type of cancer AUC* (±SEM) Sensitivity (%) Specificity (%) Criterion (ng/ml)
BC/NMF 0.911 ± 0.0179 89.3 78.0 >32.3390
BC/CRC 0.765 ± 0.0388 88.8 58.7 >33.5024
BC/KC 0.809 ± 0.0461 75.6 76.7 >35.3212
BC/LC 0.773 ± 0.0281 89.3 55.0 >32.2963
  1. *P < 0.0001.